Daniel George Wildman insider trades

Open-market stock purchases and sales by Daniel George Wildman, Director at UroGen Pharma Ltd, from SEC Form 4 filings since Nov 8, 2022.

Recent trades

DateStockTradeValue
Jun 22, 2026URGN UroGen Pharma LtdBought (not open market)—
Jun 22, 2026URGN UroGen Pharma LtdBought (not open market)—
Nov 26, 2025URGN UroGen Pharma LtdBought (not open market)—

Companies traded

  • URGN UroGen Pharma Ltd: other filings, last Jun 22, 2026

Get free alerts when Daniel George Wildman files a new trade →